ENTBF (Entheon Biomedical) Total Operating Expense: $0.21 Mil (TTM As of Feb. 2026)


What is Entheon Biomedical Total Operating Expense?

Entheon Biomedical ENTBF Total Operating Expense is $0.21 Mil as of Feb. 2026. The stock has 2 warning signs investors should review.

Entheon Biomedical's Total Operating Expense for the three months ended in Feb. 2026 was $0.07 Mil. Entheon Biomedical's Total Operating Expense for the trailing twelve months (TTM) ended in Feb. 2026 was $0.21 Mil.

Entheon Biomedical Total Operating Expense Related Terms

Entheon Biomedical Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Entheon Biomedical's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical Total Operating Expense Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23 Nov24 Nov25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only 6.54 2.82 0.41 0.24 0.24

Entheon Biomedical Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.05 0.04 0.05 0.07

Entheon Biomedical Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $0.21 Mil mean?
Entheon Biomedical (ENTBF) has a Total Operating Expense of $0.21 Mil as of Feb. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Entheon Biomedical and its competitors.
Is Entheon Biomedical's Total Operating Expense too high?
Entheon Biomedical's current Total Operating Expense is $0.21 Mil.
How does Entheon Biomedical's Total Operating Expense compare to VRTX and REGN?
Entheon Biomedical's Total Operating Expense of $0.21 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Entheon Biomedical and its competitors. Entheon Biomedical's current Total Operating Expense is $0.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entheon Biomedical stock overvalued right now?
Entheon Biomedical (ENTBF) has a current Total Operating Expense of $0.21 Mil. The current Total Operating Expense is $0.21 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Entheon Biomedical (ENTBF), the current Total Operating Expense is $0.21 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entheon Biomedical Business Description

Other Exchanges 1XU:GermanyENBI.X:Canada
Address 999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company focused on treating addiction and substance use disorders.